Organon & Co. (OGN)
NYSE: OGN · Real-Time Price · USD
7.14
0.00 (0.00%)
At close: Dec 5, 2025, 4:00 PM EST
7.12
-0.02 (-0.28%)
After-hours: Dec 5, 2025, 7:56 PM EST
Organon & Co. Stock Forecast
Stock Price Forecast
According to 4 professional analysts, the 12-month price target for Organon & Co. stock ranges from a low of $9.00 to a high of $24. The average analyst price target of $15.75 forecasts a 120.59% increase in the stock price over the next year.
Price Target: $15.75 (+120.59%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Organon & Co. stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Sell Maintains $14 → $12 | Sell | Maintains | $14 → $12 | +68.07% | Nov 11, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $10 → $9 | Hold | Maintains | $10 → $9 | +26.05% | Nov 11, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $24 → $18 | Buy | Maintains | $24 → $18 | +152.10% | May 15, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $15 → $10 | Hold | Maintains | $15 → $10 | +40.06% | May 5, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $16 → $15 | Hold | Maintains | $16 → $15 | +110.08% | Apr 9, 2025 |
Financial Forecast
Revenue This Year
6.30B
from 6.40B
Decreased by -1.59%
Revenue Next Year
6.24B
from 6.30B
Decreased by -0.94%
EPS This Year
3.81
from 3.33
Increased by 14.50%
EPS Next Year
3.97
from 3.81
Increased by 4.11%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 6.6B | 6.7B | ||||
| Avg | 6.3B | 6.2B | ||||
| Low | 6.1B | 5.8B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 2.7% | 5.6% | ||||
| Avg | -1.6% | -0.9% | ||||
| Low | -5.1% | -7.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 4.04 | 4.21 | ||||
| Avg | 3.81 | 3.97 | ||||
| Low | 3.55 | 3.73 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 21.4% | 10.4% | ||||
| Avg | 14.5% | 4.1% | ||||
| Low | 6.5% | -2.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.